Axxam is supporting the fight against COVID-19 not only applying strict contingency measures in order to protect the safety of the employees while preserving lab-based work and business continuity, but also developing in vitro assays with the aim to identify compounds to inhibit SARS-CoV-2 infection.

Meet our representatives on the event platform or contact us directly to know more about how you can support your research against COVID-19.